These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8080850)

  • 1. Recent advances in brain tumor molecular biology.
    Mikkelsen T
    Curr Opin Oncol; 1994 May; 6(3):229-34. PubMed ID: 8080850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular biology in cerebral gliomas: recent advances].
    Hoang-Xuan K; Li YJ; Hamelin R; Delattre O
    Rev Neurol (Paris); 1995 Nov; 151(11):608-18. PubMed ID: 8745624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene and chromosomal alterations associated with the development of human gliomas.
    Collins VP; James CD
    FASEB J; 1993 Jul; 7(10):926-30. PubMed ID: 8344489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy of gliomas.
    Hamel W; Westphal M
    Acta Neurochir Suppl; 2003; 88():125-35. PubMed ID: 14531570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy of malignant glioma: recent advances in experimental and clinical studies.
    Sasaki M; Plate KH
    Ann Oncol; 1998 Nov; 9(11):1155-66. PubMed ID: 9862044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenoviral gene therapy in high-grade malignant glioma.
    Pedersini R; Vattemi E; Claudio PP
    Drug News Perspect; 2010; 23(6):368-79. PubMed ID: 20697604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy of malignant gliomas: a phase I study of IL-4-HSV-TK gene-modified autologous tumor to elicit an immune response.
    Okada H; Pollack IF; Lotze MT; Lunsford LD; Kondziolka D; Lieberman F; Schiff D; Attanucci J; Edington H; Chambers W; Robbins P; Baar J; Kinzler D; Whiteside T; Elder E
    Hum Gene Ther; 2000 Mar; 11(4):637-53. PubMed ID: 10724042
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased invasion of malignant gliomas after 15-LO-1 and HSV-tk/ganciclovir combination gene therapy.
    Pacholska A; Wirth T; Samaranayake H; Pikkarainen J; Ahmad F; Ylä-Herttuala S
    Cancer Gene Ther; 2012 Dec; 19(12):870-4. PubMed ID: 23079672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 mutation, EGFR gene amplification and loss of heterozygosity on chromosome 10, 17 p in human gliomas.
    Jin W; Xu X; Yang T; Hua Z
    Chin Med J (Engl); 2000 Jul; 113(7):662-6. PubMed ID: 11776043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Towards a molecular classification of gliomas].
    Hoang-Xuan K; Idbaih A; Mokhtari K; Sanson M
    Bull Cancer; 2005 Apr; 92(4):310-6. PubMed ID: 15888387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Malignant glioma].
    Okamura K
    Nihon Rinsho; 1995 Nov; 53(11):2678-83. PubMed ID: 8538025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Perspectives on postgenome medicine: Gene therapy for brain tumors].
    Mizuno M; Yoshida J
    Nihon Rinsho; 2001 Jan; 59(1):76-80. PubMed ID: 11197866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanisms of molecular development of human glioma].
    Schlegel U
    Nervenarzt; 1993 Aug; 64(8):485-93. PubMed ID: 8413746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative effects of wild-type p53 and s-Myc on cellular growth and tumorigenicity of glioma cells. Implication of the tumor suppressor genes for gene therapy.
    Asai A; Miyagi Y; Sugiyama A; Gamanuma M; Hong SH; Takamoto S; Nomura K; Matsutani M; Takakura K; Kuchino Y
    J Neurooncol; 1994; 19(3):259-68. PubMed ID: 7807177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for malignant glioma patients.
    Puumalainen AM; Vapalahti M; Ylä-Herttuala S
    Adv Exp Med Biol; 1998; 451():505-9. PubMed ID: 10026919
    [No Abstract]   [Full Text] [Related]  

  • 16. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
    Ram Z; Culver KW; Walbridge S; Blaese RM; Oldfield EH
    Cancer Res; 1993 Jan; 53(1):83-8. PubMed ID: 8380127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results.
    Lang FF; Bruner JM; Fuller GN; Aldape K; Prados MD; Chang S; Berger MS; McDermott MW; Kunwar SM; Junck LR; Chandler W; Zwiebel JA; Kaplan RS; Yung WK
    J Clin Oncol; 2003 Jul; 21(13):2508-18. PubMed ID: 12839017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of relapsed malignant glioma with an adenoviral vector containing the herpes simplex thymidine kinase gene followed by ganciclovir.
    Smitt PS; Driesse M; Wolbers J; Kros M; Avezaat C
    Mol Ther; 2003 Jun; 7(6):851-8. PubMed ID: 12788659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The functional role of tumor suppressor genes in gliomas: clues for future therapeutic strategies.
    Fueyo J; Gomez-Manzano C; Yung WK; Kyritsis AP
    Neurology; 1998 Nov; 51(5):1250-5. PubMed ID: 9818841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity on chromosome 10, 13q(Rb), 17p, and p53 gene mutations in human brain gliomas.
    Lee SH; Kim JH; Rhee CH; Kang YS; Lee JH; Hong SI; Choi KS
    J Korean Med Sci; 1995 Dec; 10(6):442-8. PubMed ID: 8924230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.